Simplex Trading
VRCA icon

Simplex Trading’s Verrica Pharmaceuticals VRCA Stock Holding History

Simplex Trading’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-156
Closed – – 9836
2025
Q1 		$0 Sell
156
-576
-79% -$3.73K ﹤0.01% 9788
2024
Q4 		$5K Buy
732
+489
+201% +$5.38K ﹤0.01% 7674
2024
Q3 		$3K Buy
+243
New +$10.9K ﹤0.01% 7905
2024
Q2 		– Sell
-229
Closed -$17.6K – 9934
2024
Q1 		$13K Sell
229
-223
-49% -$12.3K ﹤0.01% 7445
2023
Q4 		$33K Sell
452
-499
-52% -$20.5K ﹤0.01% 6488
2023
Q3 		$36K Buy
951
+839
+749% +$42.6K ﹤0.01% 6110
2023
Q2 		$6K Buy
+112
New +$6.8K ﹤0.01% 7849
2023
Q1 		– Sell
-939
Closed -$56.8K – 10232
2022
Q4 		$25K Buy
939
+925
+6,607% +$24.7K ﹤0.01% 6667
2022
Q3 		$0 Sell
14
-80
-85% -$2.74K ﹤0.01% 10969
2022
Q2 		$1K Buy
+94
New +$4.72K ﹤0.01% 9696
2021
Q4 		– Sell
-90
Closed -$10.2K – 11541
2021
Q3 		$11K Hold
90
– – ﹤0.01% 8890
2021
Q2 		$10K Buy
+90
New +$10.9K ﹤0.01% 9115

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Simplex Trading's VRCA Position: Q2 2025 in Review

Simplex Trading sold out of Verrica Pharmaceuticals (VRCA) in Q2 2025, closing a stake of 156 shares.

Simplex Trading first reported a position in VRCA in Q2 2021 and held it in 12 quarters. The position peaked at $36K in Q3 2023. 58 funds tracked by Wall St. Rank hold VRCA as of Q2 2025.

  • Simplex Trading reported no remaining Verrica Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 156 Verrica Pharmaceuticals shares in Q2 2025.
  • Simplex Trading first reported a position in Verrica Pharmaceuticals in Q2 2021 and held it in 12 quarters.
  • Simplex Trading's Verrica Pharmaceuticals position peaked at $36K in Q3 2023.
  • 58 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.